Evidence map›Paper›PMID 41211966›Full record

ArticleMicrobiology spectrum2025

Changes in fecal microbiota after therapeutic exposure to amoxicillin-clavulanic acid in veal calves receiving multiple antibiotics.

Morgane Moustaghfir, Thibault Destanque, Pauline François, Pierre Châtre, Vanessa Louzier, Abdessalem Hammed, Karine Hauray, Jean-Yves Madec, Marisa Haenni, Caroline Prouillac and 1 more

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Morgane MoustaghfirANSES - Université de Lyon, Unité Antibiorésistance et Virulence Bactériennes, Lyon, France.
Thibault DestanqueANSES - Université de Lyon, Unité Antibiorésistance et Virulence Bactériennes, Lyon, France.
Pauline FrançoisANSES - Université de Lyon, Unité Antibiorésistance et Virulence Bactériennes, Lyon, France.
Pierre ChâtreANSES - Université de Lyon, Unité Antibiorésistance et Virulence Bactériennes, Lyon, France.
Vanessa LouzierVetAgro Sup Campus Vétérinaire de Lyon, Université de Lyon, Lyon, France.
Abdessalem HammedVetAgro Sup Campus Vétérinaire de Lyon, Université de Lyon, Lyon, France.
Karine HaurayClinique Vétérinaire du Clair Matin, Bourg-en-Bresse, France.
Jean-Yves MadecANSES - Université de Lyon, Unité Antibiorésistance et Virulence Bactériennes, Lyon, France.
Marisa HaenniANSES - Université de Lyon, Unité Antibiorésistance et Virulence Bactériennes, Lyon, France.ORCID 0000-0003-1333-5603
Caroline ProuillacVetAgro Sup Campus Vétérinaire de Lyon, Université de Lyon, Lyon, France.
Agnese LupoANSES - Université de Lyon, Unité Antibiorésistance et Virulence Bactériennes, Lyon, France.ORCID 0000-0001-5860-9511

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amoxicillin-clavulanic acid (AMC) is an important antibiotic in human and veterinary medicine. However, it can select antibiotic-resistant bacteria in the gut microbiota and alter its composition. In calves, AMC can be used to treat complicated infections. The impact of AMC on the calves' gut is unknown; thus, we analyzed the effect of a five-day AMC treatment in veal calves suffering from omphalitis. AMC-treated calves (

Indexed as

Amoxicillin-Potassium Clavulanate CombinationAnti-Bacterial AgentsBacteriaCattle DiseasesFecesGastrointestinal MicrobiomeAnimalsCattleDrug Resistance, BacterialEscherichia coliRNA, Ribosomal, 16SAmoxicillin-Potassium Clavulanate CombinationAnti-Bacterial AgentsRNA, Ribosomal, 16S16S V1-V9 sequencingamoxicillin-clavulanic acidblaCTX-MEscherichia coliESC-RintI1LachnospiraceaemicrobiotaST2325veal calves

Identifiers

PMID41211966
PMCPMC12671132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.